InvestorsHub Logo

flipper44

11/12/22 9:39 AM

#531189 RE: tryn2 #531186

I assume Dr. Liau was not hyping matters when she stated they would be “reporting out” results at SNO. She already had essentially the same abstract in Prague, so I assume her SNO presentation, and any possible accompanying external sources, will amplify both nearly identical abstracts.

dr_lowenstein

11/12/22 9:39 AM

#531190 RE: tryn2 #531186

as far as we can tell, there is no relationship between LL and NWBO, much to her credit

biosectinvestor

11/12/22 9:58 AM

#531203 RE: tryn2 #531186

1) Scientific conferences, presented by third-parties, are the same as NYAS, in terms of embargo;
2) Embargo policies can also allow for near simultaneous release of a journal article where publication is ready or close to publication, as is the case in the JAMA embargo policy.

HappyLibrarian

11/12/22 10:27 AM

#531218 RE: tryn2 #531186

Isn’t NWBO listed as part of the presentation, as an author or something like that?

If so, then that would make SNO 2022 different than NYAS 2022.

Still it’s important not to put too much hope on the JA.

It’s like a Russian nesting doll. As soon as we get past the JA it will just be another reason to stay silent and sit on their hands.

We focus on the shiny excuse, not understanding that the issue is the mentality of the company. Someone who is against transparency will always find new excuses to hide as much information as possible and keep you so focused on demolishing their newest excuse that you miss what they’ve been doing (for years at this point).